Comments on: GSK to divest tapinarof asset rights to Dermavant for £250m /news/gsk-divest-tapinarof-rights-dermavant/ The leading site for news and procurement in the pharmaceutical industry Mon, 16 Jul 2018 13:10:20 +0000 hourly 1 https://wordpress.org/?v=6.6.1